More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$131944932
P/E ratio
39.9
Dividend yield
--
Expense ratio
0.6%
Beta
0.871567
Previous close
$52.23
Today's open
$52.55
Day's range
$52.16 - $52.68
52 week range
$33.56 - $54.48
show more
Headquarters
US
Exchange
NASDAQ Global Market
Issue type
Exchange-Traded Fund
Industries
Health
4.76%
INSM
Insmed Inc
4.72%
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Seeking Alpha • Nov 11, 2025

Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
Benzinga • Sep 18, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Seeking Alpha • May 30, 2025

PTH: A Health Care Headache Worth Selling
PTH is comprised of 30+ Health Care stocks selected based on a proprietary momentum-based model. Its expense ratio is 0.60% and the ETF has $115 million in assets under management. The strategy relies on technical analysis, but that's not necessarily the issue. Instead, PTH reconstitutes quarterly, forcing managers to wait to buy stocks only after they've made their massive gains. PTH's current holdings illustrate this point perfectly. Although they've gained 51% over the last six months, the ETF itself has declined by 12% over the same period.
Seeking Alpha • Mar 10, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Alpha • Feb 25, 2025

Unwrapping 5 ETF Surprises From Secret Santa for Christmas
The current dip has made many ETFs attractive, and we call them "Secret Santa." These could surprise investors with big returns this Christmas.
Zacks Investment Research • Dec 20, 2024

Finding Opportunity in Unloved Healthcare ETFs
Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?
ETF Trends • May 31, 2024

PTH: Avoid This Momentum-Based Small-Cap Health Care ETF
PTH tracks the DWA Healthcare Technical Leaders Index, selecting U.S. Health Care stocks based on a proprietary relative strength measure. There are about 300 U.S. Health Care stocks in the selection universe. The Index only requires 30, and any point, you'll see many early-stage firms delivering exceptional short-term returns. As a result, PTH holds mostly small-cap stocks with huge recent price gains. However, the flaw is its passively-managed approach that rebalances and reconstitutes on a fixed quarterly timeline.
Seeking Alpha • Mar 13, 2024

6 Factors to Bet on Wall Street: ETFs to Buy
The Nasdaq Composite and the S&P 500 hit new all-time high Friday. However, there are chances of further rally.
Zacks Investment Research • Mar 4, 2024

ALPS' Biotech ETF SBIO Week's Top Performer
In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.
ETF Trends • Apr 24, 2023

¹ Disclosures

Open an M1 investment account to buy and sell Invesco DWA Healthcare Momentum ETF commission-free¹. Build wealth for the long term using automated trading and transfers.